Due to the diversity of the samples, we were able to interrogate the data relative to several key breast cancer risk modifiers, such as age, parity and BRCA1 or BRCA2 germline mutations, enabling us to uncover cellular interactions and compositional changes associated with each factor. The gene discussed is BRCA2; the disease is breast carcinoma.